Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-11

Clinical Trial Update: Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients [NA]

View source ↗

Summary

Clinical trial update noting completion of a study evaluating febuxostat for hyperuricemia in patients on hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Benha University | Conditions: Hyperuricemia, Hemodialysis Complication | NA | Status: COMPLETED